# SCINAI IMMUNOTHERAPEUTICS LT (SCNI)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/SCNI/

- Reporting holders: 11
- Reported value: $64.8K
- Shares held by institutions: 252,261 of 13,872,899,584 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $31.5K | 124,514 | 0.0% | 1 |
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $9.1K | 35,942 | 0.0% | 1 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $5.0K | 19,485 | 0.0% | 1 |
| [StoneX Group Inc.](https://holderbook.com/funds/913760-stonex-group-inc/) | $4.6K | 13,092 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $4.2K | 16,764 | 0.0% | 3 |
| [RHUMBLINE ADVISERS](https://holderbook.com/funds/1115418-rhumbline-advisers/) | $3.4K | 13,513 | 0.0% | 9 |
| [CAPTRUST FINANCIAL ADVISORS](https://holderbook.com/funds/1512024-captrust-financial-advisors/) | $3.0K | 12,035 | 0.0% | 1 |
| [HRT FINANCIAL LP](https://holderbook.com/funds/1475597-hrt-financial-lp/) | $3.0K | 12,088 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.0K | 3,955 | 0.0% | 9 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $15 | 58 | 0.0% | 9 |
| [ROYAL BANK OF CANADA](https://holderbook.com/funds/1000275-royal-bank-of-canada/) | $0 | 815 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 11 | $64.8K |
| Q1 2026 | 4 | $14.9K |
| Q4 2025 | 7 | $58.4K |
| Q3 2025 | 6 | $60.9K |
| Q2 2025 | 6 | $181.3K |
| Q1 2025 | 4 | $45.2K |
| Q4 2024 | 4 | $85.1K |
| Q3 2024 | 5 | $7.1K |
| Q2 2024 | 9 | $54.7K |
| Q1 2024 | 12 | $215.3K |
| Q4 2023 | 11 | $276.8K |
| Q3 2023 | 9 | $534.4K |